Header Logo

CARMELITA P ESCALANTE

TitleProfessor
InstitutionMD Anderson
DepartmentGeneral Internal Medicine
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bower JE, Lacchetti C, Alici Y, Barton DL, Bruner D, Canin BE, Escalante CP, Ganz PA, Garland SN, Gupta S, Jim H, Ligibel JA, Loh KP, Peppone L, Tripathy D, Yennu S, Zick S, Mustian K. Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol. 2024 Jul 10; 42(20):2456-2487. PMID: 38754041.
      Citations: 2     Fields:    Translation:Humans
    2. Ullah F, Song J, Rojas Hernandez CM, Kroll MH, Escalante CP, Toale KM. Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism. Oncologist. 2023 Nov 02; 28(11):e1005-e1016. PMID: 37310796; PMCID: PMC10628557.
      Citations: 1     Fields:    Translation:Humans
    3. Escalante CP. Introduction to practical aspects of cancer-associated thrombosis and related complications. Support Care Cancer. 2022 10; 30(10):8487-8489. PMID: 35779130.
      Citations:    Fields:    
    4. Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Am J Med Qual. 2018 Nov/Dec; 33(6):629-636. PMID: 29779398.
      Citations: 2     Fields:    Translation:Humans
    5. Escalante CP, Gladish GW, Qiao W, Zalpour A, Assylbekova B, Gao S, Olejeme KA, Richardson MN, Suarez-Almazor ME. Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans. Support Care Cancer. 2017 05; 25(5):1571-1577. PMID: 28070669.
      Citations: 2     Fields:    Translation:Humans
    6. Lu H, Champlin RE, Popat U, Pundole X, Escalante CP, Wang X, Qiao W, Murphy WA, Gagel RF. Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial. Bonekey Rep. 2016; 5:843. PMID: 28018583; PMCID: PMC5154364.
      Citations: 1     
    7. Escalante CP, Chang YC, Liao K, Rouleau T, Halm J, Bossi P, Bhadriraju S, Brito-Dellan N, Sahai S, Yusuf SW, Zalpour A, Elting LS, Epidemiology Section of the Mucositis Study Group of the Multinational Association of Supportive Car. Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents. Support Care Cancer. 2016 09; 24(9):4057-74. PMID: 27344327.
      Citations: 11     Fields:    Translation:Humans
    8. Escalante CP, Lu M, Marten CA. Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers. Curr Hypertens Rev. 2016; 12(2):112-20. PMID: 26931476.
      Citations: 2     Fields:    Translation:Humans
    9. Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C, National comprehensive cancer network. Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015 Aug; 13(8):1012-39. PMID: 26285247; PMCID: PMC5499710.
      Citations: 203     Fields:    Translation:Humans
    10. Yennurajalingam S, Reddy A, Tannir NM, Chisholm GB, Lee RT, Lopez G, Escalante CP, Manzullo EF, Frisbee Hume S, Williams JL, Cohen L, Bruera E. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report. Integr Cancer Ther. 2015 Sep; 14(5):419-27. PMID: 25873296.
      Citations: 8     Fields:    Translation:HumansAnimalsCTClinical Trials
    11. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB, American Society of Clinical Oncology. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol. 2014 Jun 10; 32(17):1840-50. PMID: 24733803; PMCID: PMC4039870.
      Citations: 183     Fields:    Translation:Humans
    12. Holmes HM, Nguyen HT, Nayak P, Oh JH, Escalante CP, Elting LS. Chronic conditions and health status in older cancer survivors. Eur J Intern Med. 2014 Apr; 25(4):374-8. PMID: 24389373.
      Citations: 11     Fields:    Translation:Humans
    13. Elting LS, Chang YC, Parelkar P, Boers-Doets CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International So. Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis. Support Care Cancer. 2013 Nov; 21(11):3243-54. PMID: 23636648.
      Citations: 13     Fields:    Translation:Humans
    14. Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante C, Andreeff M, Kantarjian H, Lavis V, Yeung SC. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2012 Oct; 12(5):355-62. PMID: 22658895; PMCID: PMC3974971.
      Citations: 15     Fields:    Translation:Humans
    15. Levine MN, Gu C, Liebman HA, Escalante CP, Solymoss S, Deitchman D, Ramirez L, Julian J. A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. J Thromb Haemost. 2012 May; 10(5):807-14. PMID: 22409262.
      Citations: 55     Fields:    Translation:HumansCTClinical Trials
    16. Zalpour A, Kroll MH, Afshar-Kharghan V, Yusuf SW, Escalante C. Role of factor xa inhibitors in cancer-associated thrombosis: any new data? Adv Hematol. 2011; 2011:196135. PMID: 22013445; PMCID: PMC3195274.
      Citations: 3     
    17. Escalante CP, Zalpour A. Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers. Cardiol Res Pract. 2011; 2011:816897. PMID: 21629798; PMCID: PMC3099203.
      Citations: 9     
    18. Mortimer JE, Barsevick AM, Bennett CL, Berger AM, Cleeland C, DeVader SR, Escalante C, Gilreath J, Hurria A, Mendoza TR, Rugo HS. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. 2010 Dec; 8(12):1331-9. PMID: 21147900.
      Citations: 24     Fields:    Translation:Humans
    19. Connor TH, DeBord DG, Pretty JR, Oliver MS, Roth TS, Lees PS, Krieg EF, Rogers B, Escalante CP, Toennis CA, Clark JC, Johnson BC, McDiarmid MA. Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med. 2010 Oct; 52(10):1019-27. PMID: 20881620.
      Citations: 49     Fields:    Translation:HumansPHPublic Health
    20. McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010 Oct; 52(10):1028-34. PMID: 20881619.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    21. Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI. NCCN Clinical Practice Guidelines Cancer-related fatigue. J Natl Compr Canc Netw. 2010 Aug; 8(8):904-31. PMID: 20870636.
      Citations: 78     Fields:    Translation:Humans
    22. Escalante CP, Kallen MA, Valdres RU, Morrow PK, Manzullo EF. Outcomes of a cancer-related fatigue clinic in a comprehensive cancer center. J Pain Symptom Manage. 2010 Apr; 39(4):691-701. PMID: 20226622.
      Citations: 13     Fields:    Translation:Humans
    23. Escalante CP, Manzullo EF. Cancer-related fatigue: the approach and treatment. J Gen Intern Med. 2009 Nov; 24 Suppl 2:S412-6. PMID: 19838841; PMCID: PMC2763160.
      Citations: 18     Fields:    Translation:Humans
    24. Hwang JP, Holmes HM, Kallen MA, Ensor J, Etchegaray J, Saab R, Arbuckle RB, King KM, Escalante CP. Accuracy of reporting current medications by cancer patients presenting to an emergency center. Support Care Cancer. 2010 Oct; 18(10):1347-54. PMID: 19838868.
      Citations: 1     Fields:    Translation:Humans
    25. Hwang JP, Patlan J, de Achaval S, Escalante CP. Survival in cancer patients after out-of-hospital cardiac arrest. Support Care Cancer. 2010 Jan; 18(1):51-5. PMID: 19350284.
      Citations: 7     Fields:    Translation:Humans
    26. Escalante CP, Manzullo EF, Lam TP, Ensor JE, Valdres RU, Wang XS. Fatigue and its risk factors in cancer patients who seek emergency care. J Pain Symptom Manage. 2008 Oct; 36(4):358-66. PMID: 18411011.
      Citations: 4     Fields:    Translation:Humans
    27. Elting LS, Lu C, Escalante CP, Giordano SH, Trent JC, Cooksley C, Avritscher EB, Shih YC, Ensor J, Bekele BN, Gralla RJ, Talcott JA, Rolston K. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol. 2008 Feb 01; 26(4):606-11. PMID: 18235119.
      Citations: 33     Fields:    Translation:Humans
    28. Mock V, Atkinson A, Barsevick AM, Berger AM, Cimprich B, Eisenberger MA, Hinds P, Kaldor P, Otis-Green SA, Piper BF. Cancer-related fatigue. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2007 Nov; 5(10):1054-78. PMID: 18053429.
      Citations: 31     Fields:    Translation:Humans
    29. Liu W, Vyas A, Escalante C, Weiser MA, Wang J, Geraci JM. Results of general internal medicine consultations for diabetes mellitus in 283 cancer patients. Am J Med Sci. 2007 May; 333(5):276-9. PMID: 17505168.
      Citations: 2     Fields:    Translation:Humans
    30. Geraci JM, Tsang W, Valdres RV, Escalante CP. Progressive disease in patients with cancer presenting to an emergency room with acute symptoms predicts short-term mortality. Support Care Cancer. 2006 Oct; 14(10):1038-45. PMID: 16572312.
      Citations: 22     Fields:    Translation:Humans
    31. Geraci JM, Escalante CP, Freeman JL, Goodwin JS. Comorbid disease and cancer: the need for more relevant conceptual models in health services research. J Clin Oncol. 2005 Oct 20; 23(30):7399-404. PMID: 16234509; PMCID: PMC1853249.
      Citations: 30     Fields:    Translation:Humans
    32. Escalante CP, Weiser MA, Lam T, Ho V, Yeung SC. Hypertension in cancer patients seeking acute care: an opportunity to intervene. Am J Med Sci. 2005 Sep; 330(3):120-7. PMID: 16174995.
      Citations:    Fields:    Translation:Humans
    33. Kamana M, Escalante C, Mullen CA, Frisbee-Hume S, Rolston KV. Bacterial infections in low-risk, febrile neutropenic patients. Cancer. 2005 Jul 15; 104(2):422-6. PMID: 15937905.
      Citations: 11     Fields:    Translation:Humans
    34. Weiser MA, Cabanillas M, Vu K, Tamm EP, Wallace MJ, Escalante CP, Bresalier RS. Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer. Am J Med Sci. 2005 Jul; 330(1):11-8. PMID: 16020994.
      Citations: 1     Fields:    Translation:Humans
    35. Escalante CP, Weiser MA, Manzullo E, Benjamin R, Rivera E, Lam T, Ho V, Valdres R, Lee EL, Badrina N, Fernandez S, DeJesus Y, Rolston K. Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients. Support Care Cancer. 2004 Sep; 12(9):657-62. PMID: 15185134.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    36. Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med. 2004 Aug 9-23; 164(15):1653-61. PMID: 15302635.
      Citations: 66     Fields:    Translation:Humans
    37. Gao S, Escalante C. Venous thromboembolism and malignancy. Expert Rev Anticancer Ther. 2004 Apr; 4(2):303-20. PMID: 15056060.
      Citations: 11     Fields:    Translation:Humans
    38. Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, Kantarjian HM, O'Brien SM. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004 Mar 15; 100(6):1179-85. PMID: 15022284.
      Citations: 70     Fields:    Translation:Humans
    39. Raad I, Hachem R, Hanna H, Afif C, Escalante C, Kantarjian H, Rolston K. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections. J Antimicrob Chemother. 2004 Apr; 53(4):646-9. PMID: 14998986.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    40. Avritscher EB, Cantor SB, Shih YC, Escalante CP, Rivera E, Elting LS. Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis. Support Care Cancer. 2004 Jul; 12(7):531-6. PMID: 14986076.
      Citations: 1     Fields:    Translation:Humans
    41. Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. 2003 Dec 01; 21(23):4439-43. PMID: 14645434.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    42. Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer. 2003 Sep 01; 98(5):1039-47. PMID: 12942573.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    43. Escalante CP, Manzullo E, Valdres R. A cancer-related fatigue clinic: opportunities and challenges. J Natl Compr Canc Netw. 2003 Jul; 1(3):333-43. PMID: 19761068.
      Citations: 1     Fields:    Translation:Humans
    44. Manzullo E, Liu W, Escalante C. Treatment for cancer-related fatigue: an update. Expert Rev Anticancer Ther. 2003 Feb; 3(1):99-106. PMID: 12597354.
      Citations: 3     Fields:    Translation:HumansAnimals
    45. Escalante CP. Treatment of cancer-related fatigue: an update. Support Care Cancer. 2003 Feb; 11(2):79-83. PMID: 12560935.
      Citations: 7     Fields:    Translation:Humans
    46. Manzullo EF, Escalante CP. Research into fatigue. Hematol Oncol Clin North Am. 2002 Jun; 16(3):619-28. PMID: 12170571.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    47. Escalante CP, Grover T, Johnson BA, Harle M, Guo H, Mendoza TR, Rivera E, Ho V, Lee EL, Cleeland CS. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer. 2001 Sep 15; 92(6 Suppl):1708-13. PMID: 11598891.
      Citations: 5     Fields:    Translation:Humans
    48. Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB. Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage. 2000 Nov; 20(5):318-25. PMID: 11068153.
      Citations: 10     Fields:    Translation:Humans
    49. Escalante CP, Kurtin D, Rivera E, Elting LS. Severity of illness, outcomes, and resource use in elderly cancer patients with deep venous thrombosis. Clin Appl Thromb Hemost. 2000 Jul; 6(3):175-8. PMID: 10898279.
      Citations: 1     Fields:    Translation:Humans
    50. Escalante CP, Martin CG, Elting LS, Rubenstein EB. Medical futility and appropriate medical care in patients whose death is thought to be imminent. Support Care Cancer. 1997 Jul; 5(4):274-80. PMID: 9257423.
      Citations: 4     Fields:    Translation:Humans
    51. Escalante CP, Weiser MA, Finkel K. Hyperphosphatemia associated with phosphorus-containing laxatives in a patient with chronic renal insufficiency. South Med J. 1997 Feb; 90(2):240-2. PMID: 9042182.
      Citations: 7     Fields:    Translation:Humans
    52. Escalante CP, Rubenstein EB, Rolston KV. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer. Cancer Invest. 1997; 15(3):237-42. PMID: 9171858.
      Citations: 5     Fields:    Translation:Humans
    53. Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, Kish SK, Manzullo EF, Rubenstein EB. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer. 1996 Sep 15; 78(6):1314-9. PMID: 8826956.
      Citations: 25     Fields:    Translation:Humans
    54. Escalante CP, Rubenstein EB, Rolston KV. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients. Support Care Cancer. 1996 Sep; 4(5):358-63. PMID: 8883229.
      Citations: 3     Fields:    Translation:Humans
    55. Escalante CP. Causes and management of superior vena cava syndrome. Oncology (Williston Park). 1993 Jun; 7(6):61-8; discussion 71-2, 75-7. PMID: 8318360.
      Citations: 14     Fields:    Translation:Humans
    56. Erratum. Supportive Care in Cancer. 23:2853.
    57. Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans. Supportive Care in Cancer. 1-7.
    58. Invasive group a streptococcal infection. Cancer Bulletin. 47:343-346.
    59. Update of targeted therapy-induced hypertension. Current Medical Imaging Reviews. 12:112-120.
    60. Special report. Cancer Control. 5:271-276.
    61. Ongoing Screening and Treatment to Potentially Reduce Tyrosine Kinase Inhibitor-Related Fatigue in Renal Cell Carcinoma. Journal of Pain and Symptom Management. 50:108-117.
    62. Incidence of emergency visits among oncology patients receiving outpatient chemotherapy. Cancer Control. 3:435-441.
    63. The biology of cancer-related fatigue. Supportive Care in Cancer.
    64. Fatigue. 361-373.
    65. Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents. Supportive Care in Cancer. 1-18.
    ESCALANTE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (235)
    Explore
    _
    Co-Authors (49)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _